Mirum Pharmaceuticals, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $2.4M | $52.0M | $52.0M |
| FY2019 | $16.4M | $146.7M | $12.0M |
| FY2020 | $68.8M | $240.9M | $142.1M |
| FY2021 | $174.4M | $294.7M | $31.3M |
| FY2022 | $210.9M | $352.9M | $28.0M |
| FY2023 | $398.0M | $646.6M | $286.3M |
| FY2024 | $445.1M | $670.8M | $222.5M |
| FY2025 | $528.1M | $842.8M | $296.7M |